Ríos Antonio, Rodríguez José Manuel, Moya María Rosa, Galindo Pedro José, Canteras Manuel, Alvarez María Rocío, Parrilla Pascual
Department of Surgery, Hospital Universitario Virgen de la Arrixaca, Avenida de la Libertad 208, Casillas, CP 30.007 Murcia, Spain.
Cancer. 2004 Jan 15;100(2):264-9. doi: 10.1002/cncr.11914.
The development of thyroid carcinoma may be influenced genetically and has been associated with certain HLA alleles. HLA-C alleles have not been studied in depth, because available serology techniques have not been very reliable in detecting them. However, the development of molecular biology provided an efficient and reliable technique for allele detection. The aims of the current study were to determine whether there is a significant association between any HLA-C allele and differentiated thyroid carcinoma and to establish the possible susceptibility or protection alleles related to these tumors.
HLA-C genotyping was performed in 63 patients undergoing surgery for differentiated thyroid carcinoma (57 patients with the papillary subtype and 6 patients with the follicular subtype). A representative sample of 100 nonrelated healthy Caucasians was used as a control group from the same geographic area. The polymerase chain reaction-sequence-specific primer technique was used for HLA-C genotyping. The clinical variables analyzed were age, gender, family history of thyroid pathology, residence in areas of endemic goiter, asymptomatic status, presence of hyperthyroidism, compressive symptoms, presence of an intrathoracic thyroid component, histologic variables of the tumor, and evolution. The chi-square test, the Mantel-Haenszel test, and the Bonferroni correction were used for the statistical analysis.
In the control group, a significant correlation was observed between the lower frequency of the HLA-Cw7 allele and the development of differentiated thyroid carcinoma (P < 0.05). Analysis of the different clinical variables revealed a relation between HLA-C alleles and three clinical situations: cervical lymph node involvement with HLA-Cw7 and HLA-Cw2, vascular involvement with HLA-Cw7 and HLA-Cw1, and cervical carcinoma recurrence with HLA-Cw1. However, after application of the Bonferroni correction, only the association between HLA-Cw7 and lymphatic (P(c) = 0.0483) or vascular involvement (P(c) = 0.0324) persisted.
The results revealed a relation between HLA-Cw7 and differentiated thyroid carcinoma. In future investigations, HLA-C typing may help to identify patients with a poor prognosis.
甲状腺癌的发生可能受遗传因素影响,且与某些人类白细胞抗原(HLA)等位基因有关。HLA - C等位基因尚未得到深入研究,因为现有的血清学技术在检测它们时不太可靠。然而,分子生物学的发展为等位基因检测提供了一种高效且可靠的技术。本研究的目的是确定是否存在任何HLA - C等位基因与分化型甲状腺癌之间的显著关联,并确定与这些肿瘤相关的可能的易感或保护等位基因。
对63例接受分化型甲状腺癌手术的患者(57例乳头状亚型患者和6例滤泡状亚型患者)进行HLA - C基因分型。从同一地理区域选取100名无血缘关系的健康白种人作为对照组。采用聚合酶链反应 - 序列特异性引物技术进行HLA - C基因分型。分析的临床变量包括年龄、性别、甲状腺疾病家族史、居住在地方性甲状腺肿流行地区、无症状状态、甲状腺功能亢进的存在、压迫症状、胸内甲状腺成分的存在、肿瘤的组织学变量以及病情进展。采用卡方检验、Mantel - Haenszel检验和Bonferroni校正进行统计分析。
在对照组中,观察到HLA - Cw7等位基因频率较低与分化型甲状腺癌的发生之间存在显著相关性(P < 0.05)。对不同临床变量的分析揭示了HLA - C等位基因与三种临床情况之间的关系:HLA - Cw7和HLA - Cw2与颈部淋巴结受累、HLA - Cw7和HLA - Cw1与血管受累、HLA - Cw1与宫颈癌复发。然而,应用Bonferroni校正后,仅HLA - Cw7与淋巴受累(P(c) = 0.0483)或血管受累(P(c) = 0.0324)之间的关联仍然存在。
结果揭示了HLA - Cw7与分化型甲状腺癌之间的关系。在未来的研究中,HLA - C分型可能有助于识别预后不良的患者。